Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular classification-driven stage migration and prognostic risk stratification in endometrial cancers: FIGO 2023 vs FIGO 2009.

Virchows Archiv : an international journal of pathology - 1 Aug 2026

Bakshi Neha, Modi Rahul, Arya Vandana, Kotwal Jyoti, Jain Sunila, Srivastava Mala, Aggarwal Shyam, Badwal Sonia

Abstract excerpt

The FIGO 2023 staging system of endometrial cancers (ECs) encourages integration of molecular classification with traditional histopathologic parameters for better prognostication and improved treatment decisions; however, limited availability of molecular profiling hinders its universal adoption. We aimed to assess the impact of adding molecular classification on stage migration, risk-group stratification...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Immunohistochemistry

Share to Mutation

Share to Neoplasm Staging

Share to Prognosis

Share to Risk Assessment

Source

Identifiers

PMID: 41345523
DOI: 10.1007/s00428-025-04366-1

Genes

POLE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular classification-driven stage migration and prognostic risk stratification in endometrial cancers: FIGO 2023 vs FIGO 2009.PMID 41345523Read ↗

FIGO 2023 staging system with/without molecular classification vs. FIGO 2009 in 172 endometrial cancer patients.Semantic proximity Read ↗

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer.Semantic proximity Read ↗

FIGO 2023 Staging and Molecular Classification of 172 patients with Endometrial CancerSemantic proximity Read ↗

Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort.Semantic proximity Read ↗

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read ↗

Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohortSemantic proximity Read ↗

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancerSemantic proximity Read ↗

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer.Semantic proximity Read ↗

Analysis of Differences in the Classification of Endometrial Cancer Patients in PolandSemantic proximity Read ↗

Morphomolecular Correlation and Clinicopathologic Analysis in Endometrial Carcinoma.Semantic proximity Read ↗

The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment DecisionsSemantic proximity Read ↗

Interpretation strategy of POLE, mismatch repair deficiency, and p53 in the multiple molecular classification of endometrial carcinoma and its clinical differences from single classification: a retrospective cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.